1. Adjuvant immunotherapy for solid tumors: from promise to clinical application

   • Simone Mocellin
   • Carlo R. Rossi
   • Francesco M. Marincola

   Review Pages: 583 - 595

2. Linomide administration following bone marrow transplantation in mice

   • Lola Weiss
   • Ali Abdul-Hai
   • Shimon Slavin

   Original Article Pages: 596 - 602

3. 41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases

   • Djordje Atanackovic
   • Axel Nierhaus
   • Susanna Hegewisch-Becker

   Original Article Pages: 603 - 613

4. Enhanced induction of human WT1-specific cytotoxic T lymphocytes with a 9-mer WT1 peptide modified at HLA-A*2402-binding residues

   • Akihiro Tsuboi
   • Yoshihiro Oka
   • Haruo Sugiyama

   Original Article Pages: 614 - 620

5. Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody

   • Christof Schweizer
   • Gudrun Strauss
   • Gerhard Moldenhauer

   Original Article Pages: 621 - 629

6. Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha

   • Gerard Groenewegen
   • Andries Bloem
   • Gijsbert C. de Gast

   Original Article Pages: 630 - 636

7. Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial

   • Angela Märten
   • Dimitri Flieger
   • Ingo G. Schmidt-Wolf

   Original Article Pages: 637 - 644

8. The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

   • Stephane Paul
   • Etienne Regulier
   • Bruce R. Acres

   Original Article Pages: 645 - 654

9. Analysis of the antibody repertoire of lymphoma patients

   • Shaoming Huang
   • Klaus-Dieter Preuss
   • Michael Pfreundschuh

   Original Article Pages: 655 - 662

10. Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination

    • Matthias Schott
    • Joachim Feldkamp
    • Jochen Seissler

    Original Article Pages: 663 - 668

11. Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial

    • Gabriele Pecher
    • Arnt Häring
    • Eckhard Thiel

    Original Article Pages: 669 - 673

12. Synopsis of the 4th Walker's Cay Meeting on Cancer Vaccines, 7–10 March 2002

    • Malcolm S. Mitchell
    • Martin W. Kast

    Symposium Series Pages: 674 - 676